SELL Deepak Nitrite — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)2 Nov 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
1 other SEBI-registered advisor has an active long-term SELL call on this stock
Advisor consensus · same horizon·13 Apr · 7mo ago
Nothing found in this tip’s window yet.
4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · same horizon·2 Nov · 5d ago
Why Deepak Nitrite share price jumped 9% after Q2 results - Profit and other highlights | Check rating, stock returns
NewsLivemint·30 Oct · 1w ago
Deepak Nitrite Shares Rally 9%; Q2 Profit Jumps 3.3x As Phenolics Business Delivers Record Performance
NewsNdtv-Profit·30 Oct · 1w ago
Deepak Nitrite Q2 profit more than triples to ₹398 crore as revenue jumps 62%
NewsCnbc-Tv18·29 Oct · 1w ago
Deepak Nitrite Q2 Results: Net Profit Up Multifold As Revenue Rises 62%, Margin Doubles
NewsNdtv-Profit·29 Oct · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Deepak Nitrite
- BUY — Elara Capital2 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY — Pradeep Haldar, PHD Capital30 Oct 2026 · ~1 year · target ₹1,827 · Active
- BUY — Morgan Stanley20 Oct 2026 · ~1 year · target ₹1,889 · Active
- BUY — IDBI Capital1 Sept 2026 · ~2 weeks · target ₹1,860 · SL hit
- BUY — Deven Mehata, IDBI Capital Markets and Securities1 Sept 2026 · ~2 weeks · target ₹1,930 · SL hit
More from Motilal Oswal
- BUY Zydus Lifesciences6 Nov 2026 · ~1 year · target ₹1,480 · Active
- BUY Neogen Chemicals6 Nov 2026 · ~1 year · target ₹2,765 · Active
- BUY BSE5 Nov 2026 · ~1 year · target ₹4,200 · Active
- BUY Apollo Hospitals Enterprise5 Nov 2026 · ~1 year · target ₹10,400 · Active
- BUY Bharat Electronics3 Nov 2026 · ~1 year · target ₹540 · Active

